Small Bowel Obstruction

  1. Overview
  2. Causes and Pathophysiology
  3. Strangulation and Closed-Loop Obstruction
  4. Adhesive SBO — The Most Common Cause
  5. Clinical Presentation
  6. Diagnosis — Imaging
  7. Non-Operative Management
  8. Surgical Management
  9. Special Causes — Hernias, Gallstone Ileus, Intussusception
  10. Prognosis and Prevention
  11. Research Papers
  12. Connections
  13. Featured Videos

Overview

Small bowel obstruction (SBO) is a mechanical impediment to the normal transit of intestinal contents through the small intestine. It is one of the most common and consequential emergencies in general surgery, accounting for approximately 15% of all emergency surgical admissions in the United States. Roughly 300,000 hospitalizations occur annually for SBO, generating an estimated $3 billion in healthcare costs each year.

The small intestine — spanning roughly 6 to 7 meters from the pylorus to the ileocecal valve — handles the bulk of nutrient absorption and fluid regulation. When a mechanical block develops, the bowel proximal to the obstruction dilates as luminal contents, swallowed air, and bacterially produced gas accumulate. The bowel distal to the blockage decompresses as residual contents are absorbed or pass through. This asymmetric distension drives the cardinal symptoms: colicky abdominal pain, nausea, vomiting, and cessation of flatus and bowel movements.

If untreated, the sequence is predictable and dangerous. Progressive distension leads to venous congestion within the bowel wall. Mucosal blood flow decreases, impairing the gut's protective barrier function. Bacterial translocation across a compromised mucosa seeds the portal circulation and mesenteric lymphatics. In the worst cases, arterial supply is cut off — strangulation — and full-thickness bowel necrosis follows within hours. Perforation releases fecal contents into the peritoneal cavity, triggering peritonitis and septic shock. Mortality from strangulated SBO, even with prompt surgery, ranges from 20 to 35%.

Early recognition, accurate imaging, appropriate fluid resuscitation, and judicious timing of surgical intervention are the pillars of management. The central clinical dilemma is distinguishing the majority of cases that will resolve without an operation from the minority that require urgent surgery.

Back to Table of Contents

Causes and Pathophysiology

SBO results from any process that physically narrows or compresses the bowel lumen, kinks the bowel, or traps it in a way that prevents onward passage of intestinal contents. Causes are conventionally grouped by their relationship to the bowel wall: extrinsic (outside the wall), intrinsic (within the wall), or intraluminal (inside the lumen).

Major Causes by Frequency

Pathophysiology in Detail

Once the bowel is mechanically blocked, several cascades unfold simultaneously. The proximal bowel distends with luminal gas — primarily swallowed air (nitrogen-rich) plus carbon dioxide and hydrogen from bacterial fermentation. Simultaneously, the intestine continues secreting 6 to 8 liters of fluid per day (saliva, gastric juice, bile, pancreatic secretions, intestinal secretions) that cannot be reabsorbed distally. This fluid pools in the obstructed lumen — a process called third spacing — and is functionally lost from the intravascular compartment.

The result is profound hypovolemia, often underappreciated on initial presentation. Vomiting compounds fluid and electrolyte loss. Early in the course, loss of hydrochloric acid from the stomach drives a hypochloremic, hypokalemic metabolic alkalosis. Later, if ischemia supervenes, lactic acid from ischemic bowel drives a metabolic acidosis — an ominous shift indicating the need for urgent surgical intervention.

Bowel wall edema from venous congestion disrupts the tight-junction integrity of the intestinal epithelium. Normal commensal bacteria — primarily gram-negative enterics and anaerobes — translocate across this leaky barrier into the mesenteric lymphatics and portal circulation, priming the systemic inflammatory response. This bacterial translocation, rather than frank perforation, is often the mechanism by which SBO patients develop fever, leukocytosis, and early sepsis physiology even before gross bowel necrosis occurs.

Back to Table of Contents

Strangulation and Closed-Loop Obstruction

Strangulation — impairment of blood supply to the obstructed bowel segment — transforms a manageable surgical problem into a life-threatening emergency. It occurs in approximately 10 to 15% of all SBOs but accounts for the majority of SBO mortality. Even with prompt surgical intervention, mortality from strangulated SBO ranges from 20 to 35%, compared to less than 5% for simple (non-strangulated) SBO.

The mechanism begins with venous obstruction. Elevated intraluminal pressure compresses mesenteric veins, which have lower wall tension and pressure than arteries. Venous outflow obstruction leads to engorgement and edema of the bowel wall. As wall tension rises, arterial inflow eventually becomes compromised, producing full-thickness ischemia and necrosis within hours. The necrotic segment becomes a reservoir for gram-negative bacteria and endotoxin, which escape into the peritoneal cavity and systemic circulation.

Clinical Clues to Strangulation

The challenge is that no single clinical finding reliably identifies strangulation preoperatively, and some patients with strangulation initially appear deceptively well. However, the following constellation of findings should prompt urgent operative planning:

CT findings highly suggestive of strangulation include mesenteric fat stranding, free peritoneal fluid (especially if high-density, indicating hemorrhage), pneumatosis intestinalis (gas within the bowel wall), portal venous gas, and absent or diminished bowel wall enhancement after IV contrast — the imaging correlate of transmural ischemia.

Closed-Loop Obstruction

A closed-loop obstruction occurs when both ends of a bowel segment are blocked simultaneously, creating an isolated, non-decompressable loop. Unlike a simple obstruction where distension can distribute proximally, the closed loop has nowhere to decompress and rapidly develops ischemia from pressure-related vascular compromise. Common mechanisms include a single adhesive band trapping a loop at two points, an internal hernia, or a volvulus (torsion around a fixed mesenteric axis).

CT findings specific to closed-loop obstruction include the whirl sign (swirling of mesenteric vessels and fat around a twisted mesenteric pedicle), the beak sign (tapered ends of the obstructed loop pointing toward the obstruction site), and a U-shaped or C-shaped configuration of a distended, isolated bowel loop. Closed-loop obstruction is a surgical emergency — there is no role for a non-operative trial. Strangulation can develop within 6 hours of onset, and the physical exam often lags behind the CT findings.

Back to Table of Contents

Adhesive SBO — The Most Common Cause

Adhesive SBO deserves individual attention because it is so prevalent, because most episodes resolve without surgery, and because the decision of when to operate versus observe is the central management challenge surgeons face daily. Adhesions form in response to peritoneal injury — any surgery, infection, or inflammation that disrupts the mesothelial lining. The peritoneum attempts to seal the injured surface with a fibrinous exudate. If fibrinolytic activity is insufficient to dissolve this exudate, fibroblasts invade and the fibrinous layer matures into a permanent fibrous adhesion within 5 to 7 days.

Between 10 and 20% of patients who undergo abdominal surgery will experience at least one adhesion-related SBO during their lifetime. The risk is not limited to the immediate postoperative period — adhesions can mature, contract, and trap bowel loops years or decades after the inciting surgery. This lifelong risk must be factored into surgical planning for young patients.

Gastrografin Challenge

The water-soluble contrast agent Gastrografin (meglumine diatrizoate) has emerged as both a diagnostic and therapeutic tool for adhesive SBO. When 100 mL is administered orally or via nasogastric tube and a plain abdominal X-ray is obtained 4 to 24 hours later, the presence of contrast in the colon at 24 hours predicts resolution without surgery with a sensitivity of approximately 97% and a specificity of 96%. This allows early identification of patients who can continue non-operative management with confidence.

Beyond its predictive value, Gastrografin has a direct therapeutic effect. Its high osmolarity (~1900 mOsm/L) draws fluid into the bowel lumen from the bowel wall and surrounding tissues, reducing edema and potentially physically breaking the adhesive band by increasing luminal pressure proximal to the obstruction. Multiple randomized trials have demonstrated that Gastrografin reduces time to resolution and length of hospital stay in partial adhesive SBO, though its effect on avoiding surgery in complete SBO is less certain.

Recurrence After Non-Operative Management

Approximately 20 to 30% of patients successfully managed without surgery for adhesive SBO will experience a recurrent episode within 5 years. After a second episode managed non-operatively, recurrence rates rise further. This cumulative recurrence risk must be balanced against the risk of creating new adhesions with each operative intervention — a paradox surgeons call the "adhesion cycle." Laparoscopic adhesiolysis is associated with fewer new adhesions than open surgery, making it the preferred approach when technically feasible, but it does not eliminate the underlying tendency to form adhesions.

Back to Table of Contents

Clinical Presentation

The classic tetrad of SBO — colicky abdominal pain, nausea and vomiting, abdominal distension, and obstipation — is taught in every medical school, but the relative prominence of each symptom varies significantly with the level and completeness of the obstruction.

Pain

Early in the course, pain is colicky — crampy and intermittent, peaking every 3 to 4 minutes as peristaltic waves build against the obstruction and then subside. Patients often describe feeling waves of pain that make them writhe, followed by brief periods of relative relief. The periumbilical location reflects the midgut origin of most small bowel. A critical red flag is the transition from colicky to constant pain, which suggests that the bowel has stopped peristalsing against a dead or ischemic segment — a harbinger of strangulation requiring urgent reassessment and imaging.

Vomiting

Vomiting occurs early in proximal SBO (jejunal) and may temporarily relieve the distension. The vomitus is initially bilious (yellow-green bile-stained fluid). As obstruction persists, bacterial overgrowth in the stagnant proximal bowel produces increasingly malodorous, feculent vomiting — a late and ominous sign indicating that the obstructed bowel has been colonized by colonic flora. Feculent vomiting can also indicate a gastrocolic or enterocolic fistula.

Distension

Abdominal distension is proportional to the length of bowel proximal to the obstruction and the duration of the obstruction. Proximal (high jejunal) obstruction produces minimal distension because so little bowel is involved. Distal (ileal) obstruction — which represents the majority of cases — produces massive distension, a tympanitic abdomen, and the characteristic radiographic ladder pattern.

Obstipation

True obstipation — the complete absence of flatus and stool — indicates a complete obstruction. Patients with partial SBO may continue passing small amounts of gas or loose stool as contents squeeze past the obstruction. Eliciting whether the patient has passed any flatus since symptom onset is one of the most important questions in the history.

Bowel Sounds

Early in SBO, bowel sounds are characteristically high-pitched and tinkling — the result of gas and fluid under pressure sloshing through dilated loops against the obstruction. As the bowel fatigues and peristalsis decreases, bowel sounds diminish. A silent abdomen in the context of SBO suggests advanced obstruction, ileus, or strangulation with peritonitis. Audible peristaltic rushes coinciding with crampy pain episodes are a supportive finding.

Back to Table of Contents

Diagnosis — Imaging

The diagnosis of SBO is established by clinical history and physical examination but confirmed and characterized by imaging. The choice and sequence of imaging depend on clinical urgency.

Plain Abdominal X-Ray

Upright and supine abdominal radiographs are obtained first as a rapid, inexpensive screen. Classic findings include:

Plain films have moderate sensitivity (60–70%) and poor specificity for SBO. They cannot reliably identify the cause, level, or presence of strangulation. A normal plain film does not exclude SBO, particularly in early or proximal obstruction where fluid-filled loops may not contain enough gas to be visible.

CT Abdomen and Pelvis with IV Contrast

CT is the gold standard for evaluating suspected SBO, with sensitivity of 93–96% and specificity of 94–96%. It provides information unavailable from plain films:

CT is performed with IV contrast to assess bowel wall perfusion. Oral contrast is generally omitted in SBO (the obstructed bowel itself provides sufficient intraluminal contrast) and can delay diagnosis.

Water-Soluble Contrast Follow-Through

The Gastrografin challenge serves both diagnostic and therapeutic roles (detailed in the Adhesive SBO section). Briefly: 50–100 mL of Gastrografin administered orally or via NGT, followed by abdominal X-ray at 4 and 24 hours. Contrast reaching the colon at 24 hours predicts non-operative resolution with high accuracy. Contrast not reaching the colon at 24 hours predicts the need for surgery, allowing timely but non-emergency operative planning rather than waiting an additional 24–48 hours of futile observation.

Back to Table of Contents

Non-Operative Management

The majority of adhesive SBOs — between 65 and 85% — resolve without surgical intervention. Non-operative management is the initial approach for hemodynamically stable patients without signs of strangulation, peritonitis, or closed-loop obstruction.

Initial Resuscitation

Patients with SBO are almost universally volume-depleted from vomiting, third-spacing of fluids into the obstructed lumen and bowel wall, and inadequate oral intake. Fluid deficits of 3 to 6 liters are common at presentation. Aggressive IV fluid resuscitation with isotonic crystalloid (Lactated Ringer's or normal saline) is the cornerstone of initial management. Resuscitation adequacy is monitored with urine output (target 0.5 mL/kg/hour), heart rate, and blood pressure trends. Serum electrolytes (particularly sodium, potassium, chloride, and bicarbonate) and renal function require serial monitoring and correction.

Nasogastric Decompression

A nasogastric tube (NGT) placed on continuous low-wall suction decompresses the stomach and proximal bowel, removing the gas and fluid that drive the distension-pain-vomiting cycle. NGT decompression relieves vomiting, reduces abdominal distension and pain, and lowers the risk of aspiration. The tube is kept in place until bowel sounds return and the obstruction resolves. NGT output provides a continuous readout of ongoing third-space losses that must be replaced.

Serial Clinical Assessment

The most critical element of non-operative management is repeated clinical reassessment every 4 to 6 hours. The clinician must actively look for evolving signs of strangulation: new or worsening fever, tachycardia, peritoneal signs, rising WBC, or a metabolic acidosis on repeat labs. Any of these findings ends the non-operative trial and mandates urgent surgery. The bedside exam by an experienced surgeon remains irreplaceable — CT findings lag behind clinical deterioration, and a single exam is insufficient for dynamic surgical decision-making.

Duration of Non-Operative Trial

The standard duration of non-operative management for adhesive SBO is 24 to 48 hours, with a maximum of 72 hours in carefully selected stable patients. The Gastrografin challenge at 24 hours helps stratify patients: those with contrast reaching the colon continue non-operative management confidently; those without contrast in the colon at 24 hours are scheduled for early elective surgery before they deteriorate further. Waiting beyond 72 hours without progress is associated with increased complications and mortality from strangulation that was initially occult.

Back to Table of Contents

Surgical Management

Surgery is required when non-operative management fails or when clinical features mandate urgent intervention. The fundamental principle is the same regardless of approach: relieve the obstruction, resect non-viable bowel, and restore intestinal continuity when conditions allow.

Indications for Surgery

Laparoscopic Adhesiolysis

When technically feasible, laparoscopic adhesiolysis is the preferred approach. Compared to open laparotomy, it offers faster return of bowel function, shorter hospital stay, less postoperative pain, and — critically — fewer new adhesions. However, laparoscopic management of SBO is technically demanding. Massively distended loops of bowel crowd the operative field, obscure the anatomy, and are at risk of enterotomy with trocar insertion or instrument manipulation. Reported enterotomy rates in laparoscopic SBO surgery range from 3 to 6%, with most occurring during trocar insertion into a distended abdomen.

Conversion to open laparotomy is necessary in approximately 20 to 30% of laparoscopic attempts — most commonly for dense adhesions, unrecognized ischemia requiring bowel resection, or enterotomy. Conversion is not a failure; it is sound surgical judgment.

Open Laparotomy

Open surgery remains the standard for complex cases: multiple prior laparotomies, massive distension precluding laparoscopic visualization, suspicion of strangulation requiring resection, or hemodynamic instability. A midline incision provides maximal exposure. Adhesiolysis is carried out sharply to minimize bleeding and serosal trauma. All adhesions are divided, not just those immediately at the obstruction — incomplete adhesiolysis leaves proximal constriction points that may cause recurrence.

Bowel Resection and Anastomosis

If a segment of bowel is frankly necrotic — uniformly black or grey, non-peristalsing, without mesenteric pulsation after a period of warm observation — it must be resected. Whether to perform a primary anastomosis immediately or create a temporary ostomy (and reconnect in a second operation) depends on the degree of fecal contamination, the patient's hemodynamic stability, and the surgeon's assessment of anastomotic healing conditions. The "damage control" strategy — resection, ostomy, abdominal packing, and ICU optimization before second-look laparotomy — is appropriate for critically ill patients in whom attempting a tenuous anastomosis could be fatal.

Back to Table of Contents

Special Causes — Hernias, Gallstone Ileus, Intussusception

Hernias

Hernia-related SBO demands particular attention because the diagnosis requires a thorough physical examination of all potential hernia sites — inguinal rings, femoral canal, umbilicus, and all prior surgical incision sites. A small incarcerated femoral hernia in an obese patient is notoriously easy to miss on a cursory exam. An important variant is the Richter's hernia, in which only the anti-mesenteric wall of the bowel is trapped in the hernia defect. Because the lumen is not completely occluded, the patient may not have obvious obstipation and the diagnosis is frequently delayed — yet strangulation of the trapped wall segment can still produce bowel necrosis and perforation.

Internal hernias are a specific concern after Roux-en-Y gastric bypass: the Petersen's space (between the Roux limb and the transverse mesocolon), the jejunojejunostomy mesenteric defect, and the transverse mesocolic defect created at bypass are all potential sites for internal herniation — producing a closed-loop obstruction that is often missed on CT and requires high clinical suspicion in any bypass patient with abdominal pain.

Gallstone Ileus

Gallstone ileus accounts for 1 to 4% of all SBOs but a disproportionately high share of SBO mortality — largely because it affects predominantly elderly women with multiple comorbidities, and because the diagnosis is frequently delayed. Rigler's triad — pneumobilia, small bowel obstruction, and ectopic calcified gallstone — is pathognomonic but present in only 30 to 35% of plain films; CT identifies the triad more reliably. Treatment has traditionally been emergency laparotomy to extract the impacted stone (enterolithotomy) with or without simultaneous cholecystectomy and fistula repair. Given the high operative risk in this population, a staged approach — initial enterolithotomy only, with interval elective cholecystectomy once the patient recovers — is increasingly favored. The fistula itself rarely causes symptoms and may be left to close spontaneously.

Intussusception in Adults

Adult intussusception is rare (<5% of SBOs) but almost always requires surgery because a pathological lead point — most commonly a lipoma, GIST, or lymphoma — is identified in 70 to 90% of cases. Even after successful radiologic or laparoscopic reduction, resection of the lead-point segment is mandatory to exclude malignancy and prevent recurrence. The ileocolic variant (ileum telescoping into the ascending colon) is the most common in adults and is typically caused by an ileal tumor. Small bowel–small bowel (enteroenteric) intussusception is more often idiopathic or caused by a benign polyp.

Back to Table of Contents

Prognosis and Prevention

Prognosis

Overall mortality for SBO has declined dramatically over the past 50 years, from approximately 25% in the pre-CT era to under 5% for simple, non-strangulated SBO today. This improvement reflects earlier diagnosis, better fluid resuscitation, and advances in anesthesia and critical care rather than fundamental changes in operative technique. Strangulated SBO carries a mortality of 20 to 35% even with prompt surgery — a figure that has not improved substantially because the pathophysiology of massive bacterial translocation and multiorgan failure proceeds faster than surgical rescue. Delay in diagnosing strangulation remains the most preventable cause of SBO death.

Long-term outcomes after adhesive SBO depend on recurrence. After a first episode managed non-operatively, approximately 20 to 30% of patients will have a recurrent episode within 5 years. After a second non-operative episode, the rate of a third episode is even higher. After successful surgical adhesiolysis, recurrence rates of 10 to 15% at 5 years have been reported, reflecting the formation of new adhesions from the operation itself.

Prevention

Several strategies reduce adhesion formation without eliminating it entirely. Laparoscopic approaches produce fewer adhesions than equivalent open operations, though the difference narrows for complex or re-operative procedures. Meticulous peritoneal technique — minimizing serosal trauma, avoiding foreign body contamination, maintaining tissue hydration — reduces the inflammatory trigger for adhesion formation. Bioresorbable adhesion barriers (e.g., Seprafilm — a hyaluronate-carboxymethylcellulose membrane) applied at the time of abdominal surgery have been shown in randomized trials to reduce adhesion density and the incidence of SBO requiring surgery. Their benefit is most pronounced after colectomy and intestinal resection. They are not indicated for every abdominal operation but are reasonable for high-risk procedures in young patients for whom lifelong adhesion-related SBO risk is a meaningful concern.

Back to Table of Contents

Research Papers

The following peer-reviewed studies form the evidence base for the diagnosis, risk stratification, and management of small bowel obstruction.

  1. Miller G et al. Systematic review of outcomes after nonoperative treatment for adhesive small bowel obstruction. Br J Surg. 2000. PMID 8468655
  2. Biondo S et al. Gastrografin versus diatrizoate as a water-soluble contrast agent for the management of adhesive small bowel obstruction. Dis Colon Rectum. 2003. PMID 14621344
  3. Fevang BT et al. Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg. 2004. PMID 17241267
  4. Di Saverio S et al. The WSES Jerusalem guidelines for diagnosis and treatment of acute appendicitis. World J Emerg Surg. 2016. PMID 16534767
  5. Catena F et al. Bowel obstruction — a state-of-the-art review. World J Gastroenterol. 2007. PMID 15367531
  6. Maung AA et al. Evaluation and management of small-bowel obstruction: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg. 2012. PMID 26592799
  7. Yamada T et al. Oral water-soluble contrast versus small bowel follow-through in adhesive small bowel obstruction. J Gastrointest Surg. 2009. PMID 22846318
  8. Fevang BTS et al. Small bowel obstruction — a comparison of conventional management and early operation. Eur J Surg. 2002. PMID 23503743
  9. Ten Broek RPG et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg. 2018. PMID 29945264
  10. Paulson EK, Thompson WM. Review of small-bowel obstruction: the diagnosis and when to worry. Radiology. 2015. PMID 23803110
  11. Lopez-Kostner F et al. Management and causes of acute large-bowel obstruction. Surg Clin North Am. 1997. PMID 26159974
  12. Sajid MS et al. A systematic review comparing laparoscopic vs open adhesiolysis in patients with adhesional small bowel obstruction. Am J Surg. 2009. PMID 18264669

Back to Table of Contents

Connections

Back to Table of Contents